Microwave Technology Outlasts Botulinum Toxin for Hyperhidrosis

Dr. Kaminer said that his practice participated in a registry-type study in the summer and fall of 2011 and was one of the first clinics in the country to purchase a MiraDry System, in December 2011. "Our staff has found the procedure easy to incorporate into the flow of our practice, and patients have found it to be rather easy to have done. We have seen some modest swelling for up to 1 week after treatment, but that is expected. So far, our experience has been pretty much what we would have expected, and if anything, a little better."

He added that, "Interest in offering this new treatment option to patients with excessive underarm sweating has been extremely high. Between clinics in Japan and the U.S., there have been over 1,500 patients treated."

In all, safety results have been consistent with prior experiences. "As with any procedure that we do, it is important to clearly communicate with the patients what to expect from the procedure and the recovery. Our feedback allowed the company to fine-tune their training program so that clinics that purchase the system have tools they can use to make the experience a very positive one for their patients."

Miramar is in the early stages of commercialization for the MiraDry system. It is being placed in a controlled strategy and is expected to reach "a significant number of practices across the U.S. by the middle of this year," he said.

Dr. Kaminer is chairman of the Miramar Labs scientific advisory board. His institution served as a research study site for the phase II study. SDEF and this news organization are owned by Elsevier.